Rehabilitation Outcomes in Stroke: An Observational Study

Abstract Background A comprehensive team approach for increasing stay away from bed time (SaB-time) called CASaB was conducted at multiple rehabilitation hospitals. Aims The aim of the present study was to investigate the association between SaB-time and clinical rehabilitation outcomes (CROs) before introducing CASaB (observational phase), and comparing CROs before and after CASaB (CASaB phase). Methods This prospective observational study included patients who were admitted to nine rehabilitation hospitals, with complete data. The final analysis included 197/229 patients in the observation phase, and 229/256 patients in the CASaB phase. We first tested whether SaB-time was positively associated with CROs in an observational study, then compared CROs before and after CASaB. Results In the observation phase, longer SaB-time was significantly associated with greater rehabilitation efficiency (REy) after adjusting for confounders (standardized β = 0.20, p = 0.007). In a comparison of CROs before and after CASaB, the length of hospital stay during the CASaB phase was significantly shorter than during the observational phase (61.5, 57.6–65.4 days vs 75.6, 71.4–79.9 days, p < 0.001), and the REy after CASaB was significantly greater than that before the CASaB (0.38, 0.33–0.42/day vs 0.28, 0.25–0.33/day, p = 0.006). Discussion The current results suggest that increasing SaB-time may help the recovery of functional abilities, particularly for patients in rehabilitation hospitals. Conclusions The CASaB provides a method for improving the recovery efficiency of patients in rehabilitation hospitals.

Download Full-text

Impact of Frailty on Acute Rehabilitation Outcomes: An Observational Study in a Regional Australian Context

Physical & Occupational Therapy In Geriatrics ◽

10.1080/02703181.2021.2008087 ◽

2021 ◽

pp. 1-16

Author(s):

Kate Andersen ◽

Lyndel Hewitt ◽

Kimberley J. Davis

Keyword(s):

Observational Study ◽

Rehabilitation Outcomes ◽

Australian Context ◽

Acute Rehabilitation

Download Full-text

Abstract #842: Novel Action of Saroglitazar in Patients with Diabetic Dyslipidemia – An Observational Study.

Endocrine Practice ◽

10.1016/s1530-891x(20)45176-6 ◽

2016 ◽

Vol 22 ◽

pp. 183-184

Author(s):

Hemant Thacker ◽

Rupal Shrimanker ◽

Rahul Tulle

Keyword(s):

Observational Study ◽

Diabetic Dyslipidemia

Download Full-text

47 Long-term outcome of patients treated with cardiac resynchronization. Results of a multicenter European observational study

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(05)80013-x ◽

2005 ◽

Vol 4 (1) ◽

pp. 6-6

Keyword(s):

Observational Study ◽

Cardiac Resynchronization ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

First clinical experience with the Multi-LOC multiple stent delivery system for focal stenting in long femoro-popliteal lesions

VASA ◽

10.1024/0301-1526/a000658 ◽

2017 ◽

Vol 46 (6) ◽

pp. 452-461 ◽

Cited By ~ 4

Author(s):

Klaus Amendt ◽

Ulrich Beschorner ◽

Matthias Waliszewski ◽

Martin Sigl ◽

Ralf Langhoff ◽

...

Keyword(s):

Observational Study ◽

Clinical Experience ◽

Delivery System ◽

Target Lesion ◽

Lesion Length ◽

Elastic Recoil ◽

Delivery Device ◽

Clinical Assessments ◽

Balloon Catheters ◽

Considerable Length

Abstract. Background: The purpose of this observational study is to report the six-month clinical outcomes with a new multiple stent delivery system in patients with femoro-popliteal lesions. Patients and methods: The LOCOMOTIVE study is an observational multicentre study with a primary endpoint target lesion revascularization (TLR) rate at six months. Femoro-popliteal lesions were prepared with uncoated and/or paclitaxel-coated peripheral balloon catheters. When flow limiting dissections, elastic recoil or recoil due to calcification required stenting, up to six short stents per delivery device, each 13 mm in length, were implanted. Sonographic follow-ups and clinical assessments were scheduled at six months. Results: For this first analysis, a total of 75 patients 72.9 ± 9.2 years of age were enrolled. The majority of the 176 individually treated lesions were in the superficial femoral artery (76.2 %, 134/176) whereas the rate of TASC C/D amounted to 51.1 % (90/176). The total lesion length was 14.5 ± 9.0 cm with reference vessel diameters of 5.6 ± 0.7 mm. Overall 47 ± 18 % of lesion lengths could be saved from stenting. At six months, the patency was 90.7 % (68/75) and all-cause TLR rates were 5.3 % (4/75) in the overall cohort. Conclusions: The first clinical experience at six months suggests that the MSDS strategy was safe and effective to treat femoro-popliteal lesions of considerable length (14.5 ± 9.0 cm). Almost half of the lesion length could be saved from stenting while patency was high and TLR rates were acceptably low.

Download Full-text